Your browser doesn't support javascript.
loading
What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients.
Barata, Anna; Abrams, Hannah R; Meyer, Christa; Mau, Lih-Wen; Mattila, Deborah; Burns, Linda J; Ullrich, Christina; Murthy, Hemant; Wood, William A; Petersdorf, Effie; LeBlanc, Thomas W; El-Jawahri, Areej.
Afiliação
  • Barata A; Massachusetts General Hospital, Boston, MA.
  • Abrams HR; Harvard Medical School, Boston, MA.
  • Meyer C; Massachusetts General Hospital, Boston, MA.
  • Mau LW; Harvard Medical School, Boston, MA.
  • Mattila D; National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
  • Burns LJ; National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
  • Ullrich C; National Marrow Donor Program/Be The Match and Center for International Blood and Marrow Transplant Research, Minneapolis, MN.
  • Murthy H; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.
  • Wood WA; Harvard Medical School, Boston, MA.
  • Petersdorf E; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • LeBlanc TW; Boston Children's Hospital, Boston, MA.
  • El-Jawahri A; Division of Hematology-Oncology, Mayo Clinic Florida, Jacksonville, FL.
Blood Adv ; 7(10): 2032-2041, 2023 05 23.
Article em En | MEDLINE | ID: mdl-36877661
ABSTRACT
Palliative care (PC) benefits patients undergoing hematopoietic stem cell transplantation (HSCT), but it remains underutilized. Although transplant physicians report concerns regarding how patients perceive PC, HSCT recipients' perceptions about PC remain unaddressed. We conducted a multisite, cross-sectional survey of autologous and allogeneic HSCT recipients 3 to 12 months after transplant to assess their familiarity, knowledge, and perception of PC, as well as their unmet PC needs. We computed a composite score of patients' perceptions of PC and used a generalized linear regression model to examine factors associated with these perceptions. We enrolled 69.6% (250/359) of potential participants (median age = 58.1; 63.1% autologous HSCT). Overall, 44.3.8% (109/249) reported limited knowledge about PC and 52% (127/245) endorsed familiarity with PC. Most patients felt hopeful (54%) and reassured (50%) when they heard the term PC; 83% saw referral as a sign their doctor cared about what was happening to them. In multivariate analyses, patients who were more knowledgeable about PC were more likely to have positive perceptions of PC (B = 7.54, standard error = 1.61, P < .001). Patients' demographics, HSCT features, quality of life, and symptom burden were not significantly associated with perceptions of PC. HSCT recipients have positive perceptions of PC, though many have limited knowledge about its role. Patients who were more knowledgeable about PC were more likely to have positive perceptions of PC. These data do not support transplant physicians' negative concerns about how patients perceive PC and underscore the need to further educate patients and transplant physicians about PC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cuidados Paliativos / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article